4WZ-30549-44732
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 664 / KS
- Registered
- 2021-07-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-06
Registered in v-safe
-
2021-07-06
Dose 1 — Pfizer-BioNTech
- 2021-07-06
- 2021-07-07
- 2021-07-08
- 2021-07-09
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-21
-
2021-07-27
Dose 2 — Pfizer-BioNTech
- 2021-07-27
- 2021-07-28
- 2021-07-29
- 2021-07-30
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-03
- 2021-08-10
- 2021-08-17
- 2021-08-24
- 2021-08-31
- 2021-09-07
- 2021-10-26
- 2022-01-25
-
2022-07-27
Survey response — 12 months, dose 2MedDRA: Dizziness, Nausea — Feeling: FairFree text: Nausea, dizzinessMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-06 | Pfizer-BioNTech | No |
| 2 | 2021-07-27 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 2
Symptoms: Nausea, dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release